Computational Psychiatry: how neurotechnology is changing the world of mental health ?
By Yohan Attal, Co-founder and CEO of myBrain Technologies.
PhD in brain imaging and signal processing from the Faculty of Sciences of Orsay.
Neuroscience and artificial intelligence are about to revolutionize medicine, especially psychiatry. Today, psychiatry is largely based on a patient’s subjective report of symptoms. Neurotechnologies offer a range of new tools based on objective and empirical data which will revolutionize the diagnosis and prevention of psychiatric pathologies. We are entering the era of computational medicine where digital technologies, such as magnetic resonance imaging (MRI) and electroencephalography (EEG), will play a major role in unraveling the mysteries of mood, anxiety, and depression.
Towards an ethical digital transition in psychiatry.
Psychiatry is currently facing major challenges. Doctors are ringing the alarm bells. The services are overwhelmed by the flow of patients and despite everything, a part of these patients, suffering from major mental disorders, are not being treated. This situation is only getting worse. Nearly one billion people in the world suffer from a mental disorder: a figure that is constantly increasing due to the impact of covid-19 (WHO & al., 2020)[1].
A personalized and integrated medicine, which would combine objective science and customized therapies, is becoming a necessity in helping to alleviate some of the major difficulties that psychiatry faces today.
For example, classical psychiatry still has a strong bias towards treatment with drugs, which are often necessary, but whose response to treatment brings its share of side effects.
With Computational Psychiatry, the clinical protocol embodied by the intake of a medication would be accompanied by a multidimensional analysis. It would take into account objective criteria, such as the EEG, and subjective criteria, through a personalized psychotherapy more oriented towards finding deep meaning for the patient.
Similarly, in today’s psychiatric world, patient care is increasingly complex and the patient’s journey is full of pitfalls. The categorization of pathologies is still very much focused on the declaration of symptoms, whereas a lot of additional quantitative information is now available. In addition, comorbidity and the heterogeneity of sub-populations make the classification of pathologies difficult.
Psychiatry must call upon new technologies to face these challenges. Connected tools will be able to digitize, quantify and objectify the process already in place in order to offer patients an integrative medicine that informs them, puts them at the center of the care and thus makes them proactive in their recovery.
Computational Psychiatry: at the crossroads of Digital Psychiatry, Big Psychiatry and Psychiatry Modeling.
Psychiatry has often been neglected by the medical community. The treatment and reimbursement of therapies are a problem. According to the WHO (2011)[2], psychiatric disorders would be the leading cause of disability in the world. Moreover, a report by the FondaMentale Foundation (2014, 2015)[3] highlights significant figures on the emergency situation. In the early 2010s, the estimated direct and indirect costs of mental illnesses were valued at 692 billion Euros per year in Europe, and 1,670 billion USD worldwide.
In order to face the major challenges of psychiatry today in the long term, it is possible to turn to new technologies. Indeed, the latest advances in cognitive and computational neuroscience will support psychiatry on several levels and through three fields: Digital Psychiatry, Big Psychiatry and Psychiatry Modeling.
Digital Psychiatry is based on digital health tools, such as smartphone applications or environmental sensors implemented in everyday objects, which measure physical activity, sleep or heart rate.
Gauld & al. (2020)[4], in their paper The Three Cultures of Computational Psychiatry, emphasize the link between psychiatry and statistics. The data collected thanks to these tools allow a better follow-up of the patient’s journey. They help reduce the spatio-temporal gap between a symptom and its declaration to the therapist during psychiatric consultations. They also make it possible to integrate environmental factors that can guide a diagnosis. Digital Psychiatry offers for the first time an overview of the patient’s living conditions. This connected and customized medicine will increase the relevance of data and the accuracy of diagnoses. It will also generate an enormous amount of data as a result.
Faced with this torrent of data, Big Psychiatry will provide better categorization and tracking of evolutions and dynamics for therapeutic predictions. Thus, the clinician will be supported in his diagnosis and will be able to measure the chances of success of a treatment with a maximum of information. It will also be possible to detect weak signals upstream to prevent a pathology and use the power of Big Data wisely.
Big Psychiatry offers great prospects in terms of prediction, but it is essential to understand the underlying mechanisms that govern a pathology with Psychiatry Modeling.
Beaumont & al. (2020)[5], in their paper Introduction to Computational Psychiatry, model psychiatric disorders with algorithms. They summarize the challenges of modeling in psychiatry with the analogy of David Marr, a great cognitive theorist. They explain: « Trying to understand perception by understanding neurons is like trying to understand the flight of a bird by studying only the feathers. It is simply not possible. It is essential to use an integrative medicine that takes into account the behavior of the brain, the physical and chemical makeup of the neuronal connections, its social interactions, as well as its interactions with all possible details of its environment.
Thus, psychiatry will not become a soulless medicine because of an abusive use of new technologies as some would like to make believe. It will reinvent itself in favor of a new and integrative psychiatry that better adapts to the needs of each individual.
Computational Psychiatry offers tools that will revolutionize current psychiatry. At the interface of « soft » and « hard » science, Digital Psychiatry, Big Psychiatry and Psychiatry Modeling will create a bridge between the subjective aspect of human feeling and objective and empirical data. These algorithmic and quantitative elements will not replace the intuitive dimension of the psychiatrist, nor his search for meaning. But they will enable, in a way unseen in the history of psychiatry, to accompany him in his analysis, his diagnosis and to allow better treatments.
As a radiologist today relies on imaging, the work of the psychiatrist will evolve. The expertise provided by advances in neuroscience and AI will expand and solidify the content of psychiatry, still rooted in the 20th century, and lead it into the new millennium.
References.
[1] Organisation Mondiale de la Santé, United for Global Mental Health & Fédération Mondiale pour la Santé Mentale – Communiqué de presse conjoint (27 août 2020). Journée mondiale de la santé mentale : une occasion de stimuler à grande échelle les investissements dans la santé mentale.
[2] Organisation Mondiale de la Santé (2011). Rapport mondial sur le handicap.
[3] Fondation FondaMental (2014, 2015). Les enjeux économiques de la santé mentale : perspectives et recherches internationales.
[4] Gauld C., Dumas G., Fakra É., Mattout J. & Micoukaud-Franchi J.A. (2020). Les trois cultures de la psychiatrie computationnelle. Annales Médico-Psychologiques, 179 (1), 63-71.
[5] Beaumont S., Dhôte J., Vinckier F., Palminteri S., Wyart V., Jardi R., & Domenech P. (2020). Introduction à la psychiatrie computationnelle. EMC Psychiatrie, 0 (0), 1-8 [Article 37-091-A-50].
Related Articles
A milestone for NeuroEthics
Neurotechnologies are no longer confined to research laboratories. They are fully integrated in our societies, whether in the medical field or beyond.
The benefits of collecting EEG neuroimaging insights in clinical trials.
In clinical trials, brain monitoring EEG is facilitating the measurement of complex clinical endpoints. EEG as a biomarker provides safe, objective an
Newsletter | December 2022.
During this year of 2022, we have dedicated ourselves to make our solution more complete and ergonomic through many updates designed to optimize th
Newsletter | November 2022.
The end of 2022 marks a major step forward in the neurotechnology sector in France: the presentation of a Charter for a responsible development of ne
A milestone for NeuroEthics.
The capacity of neurotechnologies to probe and interfere with brain activity challenges notions of identity, integrity and autonomy of human being. Re
Newsletter | October 2022.
To travel miles in full peace of mind, in a car that understands and anticipates every need of the driver on the road, is becoming a reality! With it
Newsletter | September 2022.
myBrain Technologies is committed to provide the most accurate offer possible to support its customers in the development of their products. With the
Newsletter | Summer 2022.
Statistics are here! Discover now our new statistic tools in Analytics to easily interpret your protocol results. Easily navigate, clearly see and qu
Newsletter | June 2022.
As a company that has developed a solution based on Artificial Intelligence (AI) and neuroscience ans as manufacturer of Medical Devices (MD), myBrain
[DOWNLOAD] Artificial Intelligence Act: What future for AI in Europe?
With the increasing evolution of computing, robotics, and new technologies, AI is now a major part of our daily life. On April 21, 2021, the European
myBrain Technologies’s eye on Medical Device Regulation.
In order to improve health safety and harmonize rules within the EU, the Medical Device Regulation has been profoundly revised, resulting in new regul
Newsletter | May 2022.
Our brain still holds many secrets, both in its functionning and in its normal development. Thanks to the latest neurosciences techniques and tools, i
NeuroAeronautics: brain wave monitoring in the ‘Cockpit of the Future’.
A cockpit is a highly sensitive area, where attention and mental workload have to be optimized. Latest neurotechnologies, including EEG, can track bra
Newsletter | April 2022.
This month, the spotlight is on user experience that our Product Team keep on improving. We aim to focus on our customer's feedback to optimize our so
NeuroDesign: to perfect the symbiosis between a product and the user experience.
One of the key aspects of product strategy is to generate, identify and leverage insights that will provide the foundation to reach business objective
Newsletter | March 2022.
Hi there! The cosmetic industry has been interested for a while in exploring the links between the brain and the nervous system. The recent advances i
NeuroCosmetics in skincare.
Cutting edge “neuro-IA” technologies can detect the physiological impact of a cosmetic product using real-time consumers’ emotional data collect
Newsletter | February 2022.
First of all, we're deeply happy to have seen so many of you reading us last month and we thank you very much! Today, we are proud to announce that o
Neuroergonomics: towards a new paradigm of product design.
Neuroergonomics provides a multidisciplinary approach that merges elements of neuroscience, human factors, and ergonomics to study brain response to s
Newsletter | January 2022.
2021 has been full of exciting happenings. Since the very beginning of our adventure, we are dedicated to improve the life of others with neuroscienc
Press Release: Decoding the brain to understand human cognition and emotions.
myBrain Tech has developed its Neuromarkers platform to record, analyze and interpret the brain's electrical signals in real time. With this solution,
[SAVE THE DATE] – AI, conquering emotions in Health!
On Tuesday, November 16, 2021, at 11am, come and listen to Giuseppe Spinelli at the microphone of Pascal Becache on the occasion of the 4th Webinar #P
Computational Psychiatry: how neurotechnology is changing the world of mental health ?
Neuroscience and artificial intelligence are about to revolutionize medicine, especially psychiatry. Neurotechnologies offer a range of new tools base
The path to ISO 13485.
Implementing a quality approach within a start-up poses particular difficulties linked to the context of innovation, agility and rapid growth. However
Get in touch
We are glad you are interested in reaching out to us. Whether you have a question about our products or want to give us feedback, we are here to help.